Eli Lilly inks deal with Bangladesh's International Agencies to supply API for human insulin
The move is part of a bid to increase access and improve insulin affordability for nearly 1 million people with diabetes in Bangladesh by 2030
Eli Lily | 15/02/2023 | By Sudeep Soparkar | 881
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy